Ximedica joins Theorem Clinical Research Strategic Alliance Group
Theorem Clinical Research has announced the addition of Ximedica, a medical product development firm, to its roster of strategic alliances.
Theorem Clinical Research
has announced the addition of
Ximedica
, a medical product development firm, to its roster of
strategic alliances
.
With deep expertise in human factors engineering, industrial design, mechanical, electrical and software engineering, advanced manufacturing services and regulatory requirements, Ximedica brings more than 25 years of experience developing medical devices, combination products and consumer health care products to the alliance.
Ximedica’s product development experience includes programs involving complex electro-mechanical systems, fluid management systems, graphical user interfaces, portable or wearable systems and systems with cutting-edge wireless technology and miniaturization solutions.
“Theorem works with Ximedica to create design solutions that meet the safety and use requirements of a wide range of populations, thereby minimizing risk during the regulatory review process,” said
D. Lee Spurgin Jr.
, Ph.D., Theorem senior vice president and general manager of
medical device and diagnostic development
. “We feel these types of business alliances allow us to offer a better end product to clients.”
“Recognizing that a growing number of our
product development programs
are requiring large-scale, multi-center global clinical studies, it made sense for Ximedica to partner with a reputable, global CRO such as Theorem. Our combined expertise provides a more compelling solution for our global clients,” said Ximedica CEO Randall S. Barko.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
